Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Alligator Bioscience and MacroGenics Enter into a Research Collaboration to Develop a Novel Immunotherapy

Friday, April 16, 2021

Alligator Bioscience announced that it has entered into a joint research collaboration with MacroGenics Inc a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibodybased therapeutics for the treatment of ca...

Arch Biopartners Enters into Worldwide License Agreement with Telara Pharma

Friday, April 16, 2021

Arch Biopartners Inc announced it has entered into an exclusive worldwide license agreement with Telara Pharma of Spain Telara to clinically develop and market cilastatin a smallmolecule drug candidate for the treatment and prevention of acute kidney...

Pure Biologics chooses to collaborate with Twist Bioscience to increase its potential in the field of phage display technology

Thursday, April 15, 2021

Twist Bioscience Corporation a company that helps customers achieve success by leveraging their highquality synthetic DNA on its silicon platform today announced a partnership with Pure Biologics to accelerate the development of new antibodybased imm...

AbCellera and Empirico Announce Strategic Multi-Target Antibody Discovery Collaboration

Thursday, April 15, 2021

AbCellera and Empirico Inc announced that they have entered into a strategic multitarget discovery collaboration Through each companys proprietary technologies the multitarget collaboration leverages hyperscale datasets

Senti Bio Enters Collaboration with Spark Therapeutics to Develop Next-Generation Precision Gene Therapies

Wednesday, April 14, 2021

Senti Biosciences a leading gene circuit company announced a collaboration and option agreement with Spark Therapeutics a member of the Roche Group to apply Senti Bios gene circuit technology to the development of nextgeneration precision gene therap...

Spark Therapeutics Enters Collaboration with Senti Bio to Bolster Industry-Leading Gene Therapy Research Platform

Wednesday, April 14, 2021

Spark Therapeutics a member of the Roche Group and a fully integrated commercial gene therapy company dedicated to challenging the inevitability of genetic disease today announced a collaboration and option agreement with Senti Biosciences

Antengene Announces First Patient Dosed in Phase II Trial of ATG-008 (Onatasertib) in Patients with Advanced Solid Tumors with Specific Genetic Alterations

Monday, April 12, 2021

Antengene Corporation Limited a leading innovative biopharmaceutical company dedicated to discovering developing and commercializing global firstinclass andor bestinclass therapeutics in hematology and oncology

HEC Pharm Selects ABEC Large-Scale Fermenters to Increase Biopharmaceutical Production Capacity

Monday, April 12, 2021

ABEC a global provider of integrated solutions and services for biopharmaceutical manufacturing announced it will design manufacture and install multiple L fermenter trains for HEC Pharms manufacturing site in Guangzhou China

Celcuity Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Gedatolisib, a First-in-Class PI3K/mTOR Inhibitor for Breast Cancer

Friday, April 09, 2021

Celcuity Inc a clinicalstage biotechnology company pursuing an integrated companion diagnostic and therapeutic strategy for treating patients with cancer today announced it has entered into a global licensing agreement with Pfizer Incgranting Celcuit...

Context Therapeutics and Integral Molecular Enter Collaboration and License Deal for Novel Claudin 6 Antibodies for Gynecologic Cancer Therapeutic Program

Friday, April 09, 2021

Context Therapeutics a clinicalstage womens oncology company developing advanced small molecule and immunotherapy treatments to transform care for hormonedriven breast and gynecological cancers